Congressional
Caucus
- Origins/Purpose
- Members
-
Briefings & Hearings
- Dec. 5, 2022: "Improving Diagnosis and Treatment Through Personalized Medicine"
- April 28, 2022: Promoting Innovation and Delivery of Cell and Gene Therapies
- Dec. 8, 2021: "The Future of Biomedicine: Translating Biomedical Research into Personalized Healthcare"
- June 30, 2020: "The Personalized Medicine Community's Response to COVID-19"
- February 26, 2020: "Technologies Advancing the Future of Personalized Medicine"
Congressional Caucus
The Congressional Personalized Medicine Caucus
February 26, 2020, Briefing
Technologies Advancing the Future of Personalized Medicine
Bringing policymakers and health care leaders from around the country to the U.S. Capitol Visitor Center, Technologies Advancing the Future of Personalized Medicine featured remarks about the importance of personalized medicine from Congressional Personalized Medicine Caucus members Reps. Tom Emmer (R-MN) and Eric Swalwell (D-CA) as well as explanations about the significance of various personalized medicine technologies by Lance Baldo, M.D., Chief Medical Officer, Adaptive Biotechnologies; Keith Stewart, M.B., Ch.B., Director, Center for Individualized Medicine, Mayo Clinic; Peter Halliburton, whose son Carter benefited from personalized medicine; and Lauren Silvis, Senior Vice President, External Affairs, Tempus. The briefing emphasized how personalized medicine can make patients healthier and make the U.S. health system more efficient by immediately targeting more effective preventive and treatment strategies to only those patients who will benefit from them.
Feb. 26, 2020
During Technologies Advancing the Future of Personalized Medicine, Personalized Medicine Caucus member Rep. Tom Emmer (R-MN) called on policymakers to “define the regulatory process to ensure that innovation isn’t stalled.”